Chemical denaturation and modification of ovalbumin alters its dependence on ubiquitin conjugation for class I antigen presentation - PubMed (original) (raw)

. 1996 Jul 15;157(2):617-24.

Affiliations

PMID: 8752909

Chemical denaturation and modification of ovalbumin alters its dependence on ubiquitin conjugation for class I antigen presentation

M T Michalek et al. J Immunol. 1996.

Abstract

Class I presentation of microinjected native OVA by a temperature-sensitive ubiquitin conjugation mutant, ts85, but not wild-type murine cells, was markedly inhibited following incubation at a nonpermissive temperature. In contrast, the nonpermissive temperature did not affect class I presentation of a minimal OVA peptide expressed in the cytosol. Therefore, these results provide a second example in which a temperature sensitive mutation in the ubiquitin conjugation pathway inhibits MHC class I presentation of native OVA. Surprisingly, incubation at the nonpermissive temperature did not inhibit class I presentation of chemically denatured and alkylated OVA microinjected into the cytosol of mutant cells. Similarly, the presentation of endogenously synthesized OVA (which is expressed from a recombinant vaccinia virus and, presumably, is misfolded in the cytosol) was also not inhibited in both mutant cell lines. Methylation of the lysine groups in denatured OVA, which blocks ubiquitin conjugation, reduced but did not eliminate the presentation of denatured OVA, providing evidence for both ubiquitin-dependent and ubiquitin-independent pathways for class I presentation. In contrast, a proteasome inhibitor blocked class I presentation of all forms of OVA, while a control peptide aldehyde was not inhibitory. These results indicate that modification of the structure of a protein can influence its requirements for ubiquitin conjugation for efficient class I presentation, with the key alteration possibly being the loss of proper conformation. However, regardless of the form of the Ag, the proteasome appears to be required for generating peptides from both endogenously synthesized and microinjected OVA for class I presentation.

PubMed Disclaimer

Cited by

DNA immunization: ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction.
Rodriguez F, Zhang J, Whitton JL. Rodriguez F, et al. J Virol. 1997 Nov;71(11):8497-503. doi: 10.1128/JVI.71.11.8497-8503.1997. J Virol. 1997. PMID: 9343207 Free PMC article.
Proteasome-dependent, ubiquitin-independent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp71 protein.
Kalejta RF, Shenk T. Kalejta RF, et al. Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3263-8. doi: 10.1073/pnas.0538058100. Epub 2003 Mar 7. Proc Natl Acad Sci U S A. 2003. PMID: 12626766 Free PMC article.
COOH-terminal truncations promote proteasome-dependent degradation of mature cystic fibrosis transmembrane conductance regulator from post-Golgi compartments.
Benharouga M, Haardt M, Kartner N, Lukacs GL. Benharouga M, et al. J Cell Biol. 2001 May 28;153(5):957-70. doi: 10.1083/jcb.153.5.957. J Cell Biol. 2001. PMID: 11381082 Free PMC article.
Identification of arginine- and lysine-methylation in the proteome of Saccharomyces cerevisiae and its functional implications.
Pang CN, Gasteiger E, Wilkins MR. Pang CN, et al. BMC Genomics. 2010 Feb 5;11:92. doi: 10.1186/1471-2164-11-92. BMC Genomics. 2010. PMID: 20137074 Free PMC article.
26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide.
Cascio P, Hilton C, Kisselev AF, Rock KL, Goldberg AL. Cascio P, et al. EMBO J. 2001 May 15;20(10):2357-66. doi: 10.1093/emboj/20.10.2357. EMBO J. 2001. PMID: 11350924 Free PMC article.

Chemical denaturation and modification of ovalbumin alters its dependence on ubiquitin conjugation for class I antigen presentation - PubMed (original) (raw)